Lignin, a low-cost byproduct of the pulp, paper and biofuels industries, could be transformed into a cheaper version of highly engineered graphite through a simple and industrially scalable manufacturing process.
– Oak Ridge National Laboratory|17-Sep-2014 10:00 AM EDT
Moffitt Cancer Center Researchers Help Lead International Efforts to Find New Genetic Links to Prostate Cancer
Researchers at Moffitt Cancer Center, including Center Director Thomas A. Sellers, Ph.D., M.P.H., Jong Park, Ph.D. and Hui-Yi Lin, Ph.D., have discovered 23 new regions of the genome that influence the risk for developing prostate cancer, according to a study published Sept. 14 in Nature Genetics.
– Moffitt Cancer Center |17-Sep-2014 10:00 AM EDT
Molecular biologists are wielding a hot new gene editing tool called CRISPR to mutate, slice, and hopefully repair virtually any spot in the genome of any animal. Neuroscientists are finally taking advantage of the new technique, with an eye toward potential therapies for genetic diseases.
– Alzforum|17-Sep-2014 10:00 AM EDT
People with bipolar disorder who do yoga believe their yoga practice has significant mental health benefits, reports a survey study in the September Journal of Psychiatric Practice. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
– Wolters Kluwer Health: Lippincott Williams and Wilkins|17-Sep-2014 9:15 AM EDT
Quantum Entanglement and Superconductivity: Upcoming Physics Talk Delves Into “Spooky Action at a Distance”
On October 1, join Dr. Subir Sachdev for a leap into the remarkable world of quantum entanglement and its connections to the technological promise of superconductivity.
– Perimeter Institute for Theoretical Physics|17-Sep-2014 9:10 AM EDT
Clinical Trial at Rutgers Cancer Institute of New Jersey Examines Vaccine-Based Treatment for Prostate Cancer
Rutgers Cancer Institute of New Jersey is one of numerous worldwide sites to offer a clinical trial examining the investigational vaccine-based treatment PROSTVAC in patients with prostate cancer that is no longer responsive to hormone therapy and has spread (metastasized) to other parts of the body. The goal of this immunotherapy study is to see if PROSTVAC improves survival when combined with a drug that helps boost the body’s ability to fight infection.
– Rutgers Cancer Institute of New Jersey|17-Sep-2014 9:00 AM EDT
People make decisions all the time, and some have long-term consequences: Do I work out? Do I take the bus? Do I recycle? A UF/IFAS researcher and his colleagues found those who value long-term consequences of their decisions are more apt to buy eco-friendly plants.
– University of Florida Institute of Food and Agricultural Sciences|17-Sep-2014 8:00 AM EDT
A study led by St. Jude Children’s Research Hospital investigators has found the chemotherapy dose threshold below which male childhood cancer survivors are likely to have normal sperm production. The study appears in September 17 edition of the journal Lancet Oncology.
– St. Jude Children's Research Hospital|16-Sep-2014 6:00 PM EDT
Cancer News Source is a Newswise initiative to promote cancer research news to the public and news media.
Newswise is where journalists choose, connect, and use smart news.
Journalists use Newswise as a source for news leads and experts from the world’s leading organizations. Members of the media can get a PressPass for access to privileged Embargoed News and expert contact information.
Newswise members use Newswise to reach the media with their news releases through our website and email wires. Members are innovative, influential organizations world-wide, including top medical schools, universities, research institutions, public relations firms, government agencies, non-profit organizations, associations and advocacy groups.
Anyone interested in knowledge-based news can register for Newswise and subscribe to the email wires.